Colin Hayward

400 total citations
22 papers, 198 citations indexed

About

Colin Hayward is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Colin Hayward has authored 22 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Colin Hayward's work include Erythropoietin and Anemia Treatment (7 papers), Renal cell carcinoma treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Colin Hayward is often cited by papers focused on Erythropoietin and Anemia Treatment (7 papers), Renal cell carcinoma treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Colin Hayward collaborates with scholars based in Switzerland, Australia and United Kingdom. Colin Hayward's co-authors include Matti Aapro, Paul Cornes, Anton Haselbeck, Wolfgang Jelkmann, Anders Österborg, Jürgen Dunst, Heinz Koelbl, G. Haensgen, Hans-Ulrich Burger and Marc Boogaerts and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurosurgery.

In The Last Decade

Colin Hayward

22 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin Hayward Switzerland	8	129	48	46	39	30	22	198
Ercan Müldür Austria	5	170 1.3×	70 1.5×	27 0.6×	26 0.7×	17 0.6×	13	276
R. Timothy Webb United States	7	66 0.5×	107 2.2×	16 0.3×	52 1.3×	48 1.6×	9	339
Magnus Adriansson Sweden	5	446 3.5×	185 3.9×	75 1.6×	27 0.7×	12 0.4×	7	508
Evgeny Shutov Russia	5	291 2.3×	6 0.1×	75 1.6×	25 0.6×	15 0.5×	15	402
John Hackmann Germany	8	26 0.2×	88 1.8×	10 0.2×	8 0.2×	24 0.8×	18	180
I V Poddubnaya Russia	7	23 0.2×	93 1.9×	6 0.1×	8 0.2×	32 1.1×	86	232
Daniela Etro Italy	6	259 2.0×	26 0.5×	5 0.1×	8 0.2×	64 2.1×	10	394
Sigvard Olsson Sweden	8	141 1.1×	24 0.5×	4 0.1×	6 0.2×	12 0.4×	10	344
Jennifer Kherani United States	10	10 0.1×	113 2.4×	3 0.1×	14 0.4×	104 3.5×	19	241
Benjamin Brown United States	8	11 0.1×	24 0.5×	2 0.0×	18 0.5×	32 1.1×	14	247

Countries citing papers authored by Colin Hayward

Since Specialization

Citations

This map shows the geographic impact of Colin Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Hayward more than expected).

Fields of papers citing papers by Colin Hayward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Hayward. The network helps show where Colin Hayward may publish in the future.

Co-authorship network of co-authors of Colin Hayward

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Hayward. A scholar is included among the top collaborators of Colin Hayward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Hayward. Colin Hayward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pichler, Josef, Tatjana Traub‐Weidinger, Arthur J. A. T. Braat, et al.. (2024). Results from a phase I study of 4- l -[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1). Neuro-Oncology Advances. 6(1). vdae130–vdae130. 4 indexed citations

Nakaigawa, Noboru, Hisashi Hasumi, Keisuke Yoshida, et al.. (2024). Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese Journal of Clinical Oncology. 54(8). 873–879. 5 indexed citations

Hawkins, Charlotte, et al.. (2024). ProstACT GLOBAL: A phase 3 study of best standard of care with and without ¹⁷⁷Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer progressing despite prior treatment with a novel androgen axis drug.. Journal of Clinical Oncology. 42(4_suppl). TPS256–TPS256. 2 indexed citations

Hasanov, Elshad, Lesley Flynt, Rebecca S. Tidwell, et al.. (2023). STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC. The Oncologist. 28(Supplement_1). S13–S13. 3 indexed citations

Shuch, Brian, Allan J. Pantuck, Jean‐Christophe Bernhard, et al.. (2023). ⁸⁹Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study.. Journal of Clinical Oncology. 41(16_suppl). 4554–4554. 6 indexed citations

Iagaru, Andrei, Amol Takalkar, Geoff S. Higgins, et al.. (2023). ⁸⁹Zr-DFO-girentuximab for PET imaging of solid tumors likely to express high levels of carbonic anhydrase IX.. Journal of Clinical Oncology. 41(6_suppl). TPS738–TPS738. 1 indexed citations

Shuch, Brian, Allan J. Pantuck, Jean‐Christophe Bernhard, et al.. (2023). Results from phase 3 study of ⁸⁹Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).. Journal of Clinical Oncology. 41(6_suppl). LBA602–LBA602. 18 indexed citations

Hayward, Colin, et al.. (2022). 823 IPAX-1: Phase ½ Study of 4-L-[131l] IODO-Phenylalanine (131I-IPA) Combined with External Radiation Therapy (XRT) as Treatment for Patients with Glioblastoma Multiforme. Neurosurgery. 68(Supplement_1). 138–139. 1 indexed citations

Antonini, Paola, Danielle Meyrick, & Colin Hayward. (2022). 177Lu-DOTA-TLX591 safety, biodistribution and dosimetry study (ProstACT-SELECT).. Journal of Clinical Oncology. 40(16_suppl). TPS5109–TPS5109. 4 indexed citations

10.

Hayward, Colin. (2011). So you want to be a pharmaceutical physician?. PubMed. 80(3). 176–176. 1 indexed citations

11.

Molenda, Olivia, et al.. (2011). Patterns of tree diversity in response to logging in Algonquin Provincial Park. 4(2). 56–62. 1 indexed citations

12.

Schnetzler, Gabriel & Colin Hayward. (2011). Overview of Guidelines and Recommendations for the Planning, Conduct and Reporting of Company-Sponsored Observational, Noninterventional Studies in Europe. Pharmaceutical Medicine. 25(4). 235–244. 1 indexed citations

13.

Hillmen, Peter, John G. Gribben, George Follows, et al.. (2009). An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL).. Blood. 114(22). 3428–3428. 8 indexed citations

14.

Schöffski, Patrick, J. Hartmann, Peter Hohenberger, et al.. (2009). 9403 Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC 62052). European Journal of Cancer Supplements. 7(2). 591–591. 1 indexed citations

15.

Haensgen, G., Jürgen Dunst, Colin Hayward, et al.. (2007). Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. International Journal of Gynecological Cancer. 18(3). 515–524. 26 indexed citations

16.

Österborg, Anders, Matti Aapro, Paul Cornes, et al.. (2006). Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. European Journal of Cancer. 43(3). 510–519. 59 indexed citations

17.

Coiffier, Bertrand, Marc Boogaerts, Matti Aapro, Colin Hayward, & Hans-Ulrich Burger. (2006). Effect of Treatment with Epoetin Beta on Thromboembolic Events in Anemic Patients with Cancer: A Metaanalysis. PubMed. 4(1). 49–55. 7 indexed citations

18.

Chan, Sze Wah Samuel, et al.. (2005). Impact of epoetin beta on the survival of anemic patients with ovarian cancer receiving platinum-based chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 5102–5102. 6 indexed citations

19.

Haensgen, G., et al.. (2005). Effects of anaemia correction with epoetin beta in patients with advanced cervical cancer and radiochemotherapy. Journal of Clinical Oncology. 23(16_suppl). 5121–5121. 9 indexed citations

20.

Hayward, Colin. (2001). Cyclone dust collectors: an underestimated technology?. Filtration & Separation. 38(10). 20–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact